- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.86 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 22 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 1 x SGV: SANGIVAMYCIN(Non-covalent)
SGV.22: 15 residues within 4Å:- Chain A: G.71, G.73, D.99, L.100, N.101, G.113, D.114, C.115, D.130, M.131, Y.132, D.133, P.134, F.149
- Ligands: EDO.2
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:D.99, A:D.99, A:L.100, A:N.101, A:D.114, A:C.115, A:Y.132, A:D.133
- Water bridges: A:G.71, A:D.114
- 2 x ZN: ZINC ION(Non-covalent)
ZN.25: 6 residues within 4Å:- Chain B: C.75, Y.77, C.78, H.84, C.91, K.94
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.75, B:C.78, B:H.84, B:C.91
ZN.26: 5 residues within 4Å:- Chain B: C.118, V.120, C.121, C.129, C.131
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.118, B:C.121, B:C.129, B:C.131
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kremling, V. et al., SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug discovery. Elife (2024)
- Release Date
- 2023-05-10
- Peptides
- 2'-O-methyltransferase nsp16: A
Non-structural protein 10: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.86 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 22 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 1 x SGV: SANGIVAMYCIN(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kremling, V. et al., SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug discovery. Elife (2024)
- Release Date
- 2023-05-10
- Peptides
- 2'-O-methyltransferase nsp16: A
Non-structural protein 10: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B